SEHA Corniche delivers 1.99kg IVF baby after 8 pregnancy losses

SEHA Corniche Hospital in Abu Dhabi has reported the live birth of a baby girl to Afra Al Khateeri, a 41-year-old patient from the northern emirates, after seven miscarriages and one foetal death.

The case matters first to fertility and maternity operators. It shows how IVF, pre-implantation genetic testing, high-risk obstetrics and neonatal care now sit in one commercial and clinical pathway. For insurers, it raises the underwriting question behind complex assisted reproduction: which parts are infertility treatment, which are genetic risk management, and which are maternity or neonatal claims.

What happened at Corniche

According to Menafn, citing SEHA, the patient conceived through IVF after PGT-A and PGT-M. Both parents are carriers of the EXOC3L2 gene, which SEHA linked to brain malformations and renal disease. The pregnancy was complicated by a uterine septum, gestational diabetes, late-onset intrauterine growth restriction and a history of multiple surgeries.

Al Khateeri was admitted to Corniche Hospital at 35 weeks. The baby was delivered by C-section with a birth weight of 1.99kg. Mother and baby stayed in hospital for nearly two weeks, and the infant was discharged at 2.0kg after specialist neonatal care.

“This remarkable case reflects the deep trust that families across the UAE place in Corniche Hospital.” Dr Saleema Wani, Chief Medical Officer and Consultant in Obstetrics and Gynaecology, SEHA Corniche Hospital.

For medical directors, the clinical point is the sequence of care. Recurrent pregnancy loss, carrier status, endometriosis, uterine surgery, diabetes and fetal growth restriction each change consent, monitoring and escalation. Clinics selling IVF in isolation will struggle when cases move into maternal-fetal medicine and neonatal intensive care.

Why Dubai clinics and insurers should watch

Dubai fertility centres operate under the Dubai Health Authority (DHA). DHA’s Assisted Reproductive Medicine Center standards set requirements for assisted reproduction services, including genetic screening before embryo transfer. Abu Dhabi providers are regulated by the Department of Health Abu Dhabi (DOH). Providers in Sharjah, Ajman, Umm Al Quwain, Ras Al Khaimah and Fujairah fall under the Ministry of Health and Prevention (MOHAP).

The financial exposure is material for patients and payers. Published UAE price guides and clinic packages usually put a basic IVF cycle in the broad range of AED 15,000 to AED 45,000. IVF with ICSI and PGT can move above that once medications, embryo testing, freezing, transfer and antenatal care are added. Operators should quote itemised pathways, rather than one headline cycle price.

• COOs should audit referral agreements between IVF, fetal medicine, obstetrics, endocrinology and neonatal intensive care.
• CFOs should separate IVF lab revenue from high-risk maternity and neonatal billing, because the payer logic differs.
• CIOs should check whether genetic test results, embryo records and obstetric notes are visible across the care team.
• Medical directors should review consent templates for PGT, recurrent pregnancy loss and preterm delivery risk.

The insurance position is uneven. Thiqa, managed by Daman, lists infertility treatment with a maximum of three attempts per year for eligible members, and Daman’s 2026 assisted reproductive treatment policy refers to pre-authorisation for embryo genetic screening. Some commercial policies exclude IVF or embryo transfer. Sukoon policy documents include exclusions for IVF in some plans. Patients should ask their insurer for written confirmation by CPT or service code before stimulation starts.

What patients and operators should do next

For patients, the question is no longer only where IVF is available. It is whether the provider can manage the next complication. Couples with recurrent pregnancy loss, maternal age above 35, known carrier status or prior uterine surgery should ask for age-stratified success rates, PGT indications, embryo storage terms, neonatal access and the name of the regulator licensing the facility.

For operators, the Corniche case is a signal to make high-risk IVF pathways explicit. Dubai providers should align documentation with DHA standards. Abu Dhabi providers should check DOH licensing, Thiqa billing rules and pre-authorisation workflows. Northern emirates providers should verify MOHAP requirements before marketing cross-emirate IVF pathways.

Patients and referring clinicians can compare licensed fertility IVF providers through the UAE Open Healthcare Directory, then confirm each facility’s current licence, services and insurance acceptance before booking treatment.